• Home  
  • Enovis Enters Binding Offer to Acquire eCential Robotics
- News

Enovis Enters Binding Offer to Acquire eCential Robotics

The acquisition of eCential Robotics is expected to strengthen and expand Enovis’ ASTRA enabling technology ecosystem by adding robotic automation capabilities.

Enovis to Acquire eCential Robotics, Expand Orthopaedic Portfolio

Image: eCential Robotics Platform

US-based Enovis Corporation has entered into a binding offer to acquire eCential Robotics, a French medical technology company specialising in robotic and navigation solutions for orthopaedic surgery.

Following completion of the information and consultation process with eCential Robotics’ works council, in accordance with French law, the parties expect to enter into a definitive purchase agreement. The transaction is expected to close in the fourth quarter of 2026, subject to regulatory approvals.

Announcing the binding offer from Enovis, eCential Robotics said its expertise in robotics engineering, software development and surgical automation complements Enovis’ existing technology portfolio while adding capabilities that could accelerate its innovation roadmap.

eCential Robotics’ Op.n platform integrates surgical navigation and active robotics into a single architecture. The platform is FDA 510(k)-cleared for spine surgery in the US and provides a foundation for future innovation. 

The acquisition is expected to strengthen and expand Enovis’ ASTRA enabling technology ecosystem by adding robotic automation capabilities, creating a more comprehensive ecosystem designed to improve surgical precision, streamline workflows and enhance patient outcomes.

Clément Vidal, CEO, eCential Robotics, said, “As part of Enovis, we will be able to grow through a shared mission to support surgeons with greater operating room efficiency and help patients live more full, active lives. I am truly excited about the opportunities we will unlock together.”

Enovis CEO Damien McDonald described the acquisition as a significant milestone that reflects the company’s disciplined approach to bringing externally developed innovation into Enovis.

“The eCential Robotics team brings exceptional engineering talent, intellectual property and a proven track record of bringing innovative robotic solutions to market. Their expertise will serve as the bedrock of our robotics strategy and enable Enovis to win in surgical enabling technology,” he said.

Stéphane Lavallée, Founder and Chair of eCential Robotics added, “Enovis brings focus, speed and a real commitment to the future of eCential Robotics. Together, the combined companies will continue to support existing partnerships and build a centre of excellence for robotics in Grenoble focused on advancing the shared innovation roadmap.”

About Us

HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.

Contact: +91 9354115542

HealthXploreIndia @2026. All Rights Reserved.